Journal of NeuroVirology

, Volume 16, Issue 5, pp 368–376

Exploring the relationship of macrophage colony-stimulating factor levels on neuroaxonal metabolism and cognition during chronic human immunodeficiency virus infection

  • Margaret R Lentz
  • Mahaveer Degaonkar
  • Mona A Mohamed
  • Hyun Kim
  • Katherine Conant
  • Elkan F Halpern
  • Ned Sacktor
  • Peter B Barker
  • Martin G Pomper
Article

DOI: 10.3109/13550284.2010.513029

Cite this article as:
Lentz, M.R., Degaonkar, M., Mohamed, M.A. et al. Journal of NeuroVirology (2010) 16: 368. doi:10.3109/13550284.2010.513029

Abstract

Macrophage colony-stimulating factor (M-CSF) promotes macrophage differentiation, increases susceptibility of macrophages to viral infection, and enhances human immunodeficiency virus (HIV) replication in infected macrophages. Given the current model of HIV neuropathogenesis, which involves monocyte trafficking into the central nervous system, immune factors linked with macrophage maturation and survival may be associated with cognitive decline (measured by neuropsychological z-score [NPZ-8] or Memorial Sloan-Kettering [MSK] score) and alterations in a marker of neuronal integrity,N-acetylaspartate (NAA). Fifty-four chronically infected HIV+ subjects underwent neuropsychological assessment, magnetic resonance spectroscopic imaging, and quantification of M-CSF in plasma and cerebrospinal fluid (CSF) at baseline. Thirty-nine of those subjects underwent further examination at 3 and 10 months after initiation of combination antiretroviral therapy (ART) regimens. Within 3 months of therapy use, CSF M-CSF and viral RNA levels were reduced, whereas NAA concentrations in many brain regions were increased. Neither baseline levels nor the change in M-CSF levels had the ability to predict changes in NAA levels observed after 10 months of combination ART use. At study entry those with the lowest M-CSF levels in the CSF had the least cognitive impairment (NPZ-8). Those who had higher baseline CSF MCSF levels and exhibited larger decreases in M-CSF after therapy, tended to have greater cognitive improvement after 10 months. Increased prevalence of M-CSF in the setting of HIV infection could contribute to neuronal injury and may be predictive of cognitive impairment.

Keywords

ADM-CSFMRSMSKNAANPZ-8

Copyright information

© Journal of NeuroVirology, Inc. 2010

Authors and Affiliations

  • Margaret R Lentz
    • 1
  • Mahaveer Degaonkar
    • 2
  • Mona A Mohamed
    • 2
  • Hyun Kim
    • 1
  • Katherine Conant
    • 1
  • Elkan F Halpern
    • 1
  • Ned Sacktor
    • 1
  • Peter B Barker
    • 2
  • Martin G Pomper
    • 2
  1. 1.Department of Neuroradiology and the A. A. Martinos Center for Biomedical ImagingMassachusetts General HospitalCharlestownUSA
  2. 2.Russell H. Morgan Department of Radiology and Radiological ScienceUSA
  3. 3.Department of NeurologyMD, PhD, Johns Hopkins Medical InstitutionsBaltimoreUSA.